Besides, PTPRN was highly expressed in NSCLC patients with distant metastasis and lymph-node metastasis compared with non-metastatic NSCLC patients (Figure 3B). This evidence concerns the gene PTPRN and metastatic malignant neoplasm in the lymph nodes.